Safety, Tolerability and Pharmacokinetics of ETD-001 Gel
Clinical trial NCT07674862 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07674862
- Sponsor
- Etern Therapeutics Wuxi Limited
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2026-07-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.